Cleared Traditional

K251366 - EEG-1260A Neurofax System (EEG-1260A) (FDA 510(k) Clearance)

Also includes:
JE-940A EEG Amplifier Unit (JE-940A) LS-940A Photic Stimulator (LS-940A)
Oct 2025
Decision
161d
Days
Class 2
Risk

K251366 is an FDA 510(k) clearance for the EEG-1260A Neurofax System (EEG-1260A). This device is classified as a Non-normalizing Quantitative Electroencephalograph Software (Class II - Special Controls, product code OLT).

Submitted by Nihon Kohden Corporation (Tokyo, JP). The FDA issued a Cleared decision on October 9, 2025, 161 days after receiving the submission on May 1, 2025.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Analyze Electroencephalograph Data Using Conventional Methodology To Output And Display Standard Electroencephalograph Parameters For Interpretation By A Qualified User..

Submission Details

510(k) Number K251366 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 01, 2025
Decision Date October 09, 2025
Days to Decision 161 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OLT - Non-normalizing Quantitative Electroencephalograph Software
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Analyze Electroencephalograph Data Using Conventional Methodology To Output And Display Standard Electroencephalograph Parameters For Interpretation By A Qualified User.